The South Korea immunoglobulin market is expected to develop with a CAGR of 8.11% in terms of revenue during the estimated period, acquiring a revenue share of $936.18 million by 2028. The base year regarded for the market study is 2021, while the forecast years are from 2022 to 2028. SOUTH KOREA IMMUNOGLOBULIN MARKET FORECAST... Read more
- HOME
- ABOUT US
- INDUSTRIES
- REGIONAL REPORTS
- CONSULTING SERVICE
- CONTACT US
- MEDIA
- INDUSTRY WHITEPAPER